Skip to main content
Top
Published in: EJNMMI Research 1/2019

Open Access 01-12-2019 | Hyperparathyroidism | Original research

The role of 18F-FCH PET/CT in patients with uremic hyperparathyroidism compared with 99mTc-sestaMIBI SPECT/CT and ultrasonography

Authors: Yu Xue, Wenbo Li, Zhu Xia, Chengming Lei, Yiyi Cao, Zhengjie Wang, Hua Pang

Published in: EJNMMI Research | Issue 1/2019

Login to get access

Abstract

Background

The aim of this study was to evaluate the diagnostic efficacy of 18F-fluorocholine (18F-FCH) PET/CT for uremic hyperparathyroidism (uHPT) compared to 99mTc-sestaMIBI SPECT/CT and ultrasonography (US).

Methods

A total of 17 uHPT patients with stage 5 chronic kidney disease (CKD) were prospectively enrolled. All patients underwent US, 99mTc-sestaMIBI SPECT/CT, and 18F-FCH within 2 months and received surgical treatment. Visual and quantitative methods were used for image analyses. Intraoperative localization and postoperative histological results of the reference standard as well as the sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) of the three modalities were analyzed using Pearson’s χ2 tests. In addition, the diagnostic efficacy of 18F-FCH PET/CT for uHPT was evaluated. The relationships between PET parameters and laboratory parameters were assessed using the Spearman correlation coefficient.

Results

A total of 63 parathyroid hyperplasia lesions were resected in 17 uHPT patients, and 53 lesions were detected using 18F-FCH PET/CT with no false-positive results. The sensitivity, specificity, accuracy, PPV, and NPV were 84.13%, 100%, 86.49%, 100%, and 52.38%, respectively. In comparison, the corresponding values for 99mTc-sestaMIBI SPECT/CT and US were 63.49%, 90.91%, 67.57%, 97.56%, and 30.30% and 61.90%, 81.82%, 64.86%, 95.12%, and 27.27%, respectively. The volume of hyper-functioning parathyroid glands was significantly different between lesions positive in 18F-FCH PET/CT and negative in 18F-FCH PET/CT (mean volume 1.36 ± 0.55 cm3 vs. 0.83 ± 0.26 cm3; P = 0.019). US misidentified intrathyroidal parathyroid hyperplasia as thyroid nodules in three patients, while 18F-FCH PET correctly identified the anatomy. No significant associations were observed between PET parameters and laboratory parameters in uHPT.

Conclusion

18F-FCH PET/CT was more sensitive and accurate for uHPT than 99mTc-sestaMIBI SPECT/CT and US, and had better preoperative diagnostic efficacy, particularly for lesions diagnosed as a thyroid nodule by US.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cabo J, Gallagher KC, Baregamian N. Challenges and controversies in the surgical management of uremic hyperparathyroidism: a systematic review. Am J Surg. 2018;216(4):713–22.CrossRef Cabo J, Gallagher KC, Baregamian N. Challenges and controversies in the surgical management of uremic hyperparathyroidism: a systematic review. Am J Surg. 2018;216(4):713–22.CrossRef
2.
go back to reference Lu CL, et al. The emerging role of nutritional vitamin d in secondary hyperparathyroidism in CKD. Nutrients. 2018;10(12):1890.CrossRef Lu CL, et al. The emerging role of nutritional vitamin d in secondary hyperparathyroidism in CKD. Nutrients. 2018;10(12):1890.CrossRef
3.
go back to reference Dulfer RR, et al. Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis. Langenbecks Arch Surg. 2019;404(1):71–9.CrossRef Dulfer RR, et al. Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis. Langenbecks Arch Surg. 2019;404(1):71–9.CrossRef
4.
go back to reference Pitt SC, Sippel RS, Chen H. Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin North Am. 2009;89(5):1227–39.CrossRef Pitt SC, Sippel RS, Chen H. Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin North Am. 2009;89(5):1227–39.CrossRef
5.
go back to reference Dulfer RR, et al. Systematic review of surgical and medical treatment for tertiary hyperparathyroidism. Br J Surg. 2017;104(7):804–13.CrossRef Dulfer RR, et al. Systematic review of surgical and medical treatment for tertiary hyperparathyroidism. Br J Surg. 2017;104(7):804–13.CrossRef
6.
go back to reference Tang JA, et al. Parathyroidectomy for tertiary hyperparathyroidism: a systematic review. Am J Otolaryngol. 2017;38(5):630–5.CrossRef Tang JA, et al. Parathyroidectomy for tertiary hyperparathyroidism: a systematic review. Am J Otolaryngol. 2017;38(5):630–5.CrossRef
7.
go back to reference Ketteler M, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters. Kidney Int. 2017;92(1):26–36.CrossRef Ketteler M, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters. Kidney Int. 2017;92(1):26–36.CrossRef
8.
go back to reference Bo SJ, et al. Re-operation treatment in uremic patients complicated with persistent secondary hyperparathyroidism after parathyroidectomy with autotransplantation. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018;32(2):142–7.PubMed Bo SJ, et al. Re-operation treatment in uremic patients complicated with persistent secondary hyperparathyroidism after parathyroidectomy with autotransplantation. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018;32(2):142–7.PubMed
9.
go back to reference Lezaic L, et al. (1)(8)F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study. Eur J Nucl Med Mol Imaging. 2014;41(11):2083–9.CrossRef Lezaic L, et al. (1)(8)F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study. Eur J Nucl Med Mol Imaging. 2014;41(11):2083–9.CrossRef
10.
go back to reference Kuzminski SJ, Sosa JA, Hoang JK. Update in parathyroid imaging. Magn Reson Imaging Clin N Am. 2018;26(1):151–66.CrossRef Kuzminski SJ, Sosa JA, Hoang JK. Update in parathyroid imaging. Magn Reson Imaging Clin N Am. 2018;26(1):151–66.CrossRef
11.
go back to reference Hodolic M, et al. Incidental uptake of (18)F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer. Radiol Oncol. 2014;48(3):228–34.CrossRef Hodolic M, et al. Incidental uptake of (18)F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer. Radiol Oncol. 2014;48(3):228–34.CrossRef
12.
go back to reference Michaud L, et al. A pilot comparison of 18F-fluorocholine PET/CT, ultrasonography and 123I/99mTc-sestaMIBI dual-phase dual-isotope scintigraphy in the preoperative localization of hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism: influence of thyroid anomalies. Medicine (Baltimore). 2015;94(41):e1701.CrossRef Michaud L, et al. A pilot comparison of 18F-fluorocholine PET/CT, ultrasonography and 123I/99mTc-sestaMIBI dual-phase dual-isotope scintigraphy in the preoperative localization of hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism: influence of thyroid anomalies. Medicine (Baltimore). 2015;94(41):e1701.CrossRef
13.
go back to reference Thanseer N, et al. Comparative effectiveness of ultrasonography, 99mTc-Sestamibi, and 18F-fluorocholine PET/CT in detecting parathyroid adenomas in patients with primary hyperparathyroidism. Clin Nucl Med. 2017;42(12):e491–7.CrossRef Thanseer N, et al. Comparative effectiveness of ultrasonography, 99mTc-Sestamibi, and 18F-fluorocholine PET/CT in detecting parathyroid adenomas in patients with primary hyperparathyroidism. Clin Nucl Med. 2017;42(12):e491–7.CrossRef
14.
go back to reference Hocevar M, et al. Focused parathyroidectomy without intraoperative parathormone testing is safe after pre-operative localization with (18)F-fluorocholine PET/CT. Eur J Surg Oncol. 2017;43(1):133–7.CrossRef Hocevar M, et al. Focused parathyroidectomy without intraoperative parathormone testing is safe after pre-operative localization with (18)F-fluorocholine PET/CT. Eur J Surg Oncol. 2017;43(1):133–7.CrossRef
15.
go back to reference Caroli P, et al. Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide. Eur J Nucl Med Mol Imaging. 2018;45(3):348–54.CrossRef Caroli P, et al. Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide. Eur J Nucl Med Mol Imaging. 2018;45(3):348–54.CrossRef
16.
go back to reference Sardiwal S, et al. Bone alkaline phosphatase in CKD-mineral bone disorder. Am J Kidney Dis. 2013;62(4):810–22.CrossRef Sardiwal S, et al. Bone alkaline phosphatase in CKD-mineral bone disorder. Am J Kidney Dis. 2013;62(4):810–22.CrossRef
17.
go back to reference Kluijfhout WP, et al. (18)F Fluorocholine PET/MR imaging in patients with primary hyperparathyroidism and inconclusive conventional imaging: a prospective pilot study. Radiology. 2017;284(2):460–7.CrossRef Kluijfhout WP, et al. (18)F Fluorocholine PET/MR imaging in patients with primary hyperparathyroidism and inconclusive conventional imaging: a prospective pilot study. Radiology. 2017;284(2):460–7.CrossRef
18.
go back to reference Beheshti M, et al. (18)F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with (99 m)Tc-MIBI or (99 m)Tc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients. Eur J Nucl Med Mol Imaging. 2018;45(10):1762–71.CrossRef Beheshti M, et al. (18)F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with (99 m)Tc-MIBI or (99 m)Tc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients. Eur J Nucl Med Mol Imaging. 2018;45(10):1762–71.CrossRef
19.
go back to reference Araz M, et al. The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism. Nucl Med Commun. 2018;39(11):989–94.CrossRef Araz M, et al. The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism. Nucl Med Commun. 2018;39(11):989–94.CrossRef
20.
go back to reference Bilezikian JP, et al. Hyperparathyroidism. Lancet. 2018;391(10116):168–78.CrossRef Bilezikian JP, et al. Hyperparathyroidism. Lancet. 2018;391(10116):168–78.CrossRef
21.
go back to reference Alharbi AA, et al. [(18)F]Fluorocholine uptake of parathyroid adenoma is correlated with parathyroid hormone level. Mol Imaging Biol. 2018;20(5):857–67.CrossRef Alharbi AA, et al. [(18)F]Fluorocholine uptake of parathyroid adenoma is correlated with parathyroid hormone level. Mol Imaging Biol. 2018;20(5):857–67.CrossRef
22.
go back to reference Botushanova AD, Botushanov NP, Yaneva MP. Nuclear medicine methods for evaluation of abnormal parathyroid glands in patients with primary and secondary hyperparathyroidism. Folia Med (Plovdiv). 2017;59(4):396–404.CrossRef Botushanova AD, Botushanov NP, Yaneva MP. Nuclear medicine methods for evaluation of abnormal parathyroid glands in patients with primary and secondary hyperparathyroidism. Folia Med (Plovdiv). 2017;59(4):396–404.CrossRef
23.
go back to reference Michaud L, et al. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab. 2014;99(12):4531–6.CrossRef Michaud L, et al. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab. 2014;99(12):4531–6.CrossRef
24.
go back to reference Prabhu M, Damle NA. Fluorocholine PET Imaging of Parathyroid Disease. Indian J Endocrinol Metab. 2018;22(4):535–41.CrossRef Prabhu M, Damle NA. Fluorocholine PET Imaging of Parathyroid Disease. Indian J Endocrinol Metab. 2018;22(4):535–41.CrossRef
25.
go back to reference Rep S, et al. (18)F-choline PET/CT for parathyroid scintigraphy: significantly lower radiation exposure of patients in comparison to conventional nuclear medicine imaging approaches. J Radiol Prot. 2018;38(1):343–56.CrossRef Rep S, et al. (18)F-choline PET/CT for parathyroid scintigraphy: significantly lower radiation exposure of patients in comparison to conventional nuclear medicine imaging approaches. J Radiol Prot. 2018;38(1):343–56.CrossRef
26.
go back to reference Bergeret S, et al. Novel PET tracers: added value for endocrine disorders. Endocrine. 2019;64(1):14–30.PubMed Bergeret S, et al. Novel PET tracers: added value for endocrine disorders. Endocrine. 2019;64(1):14–30.PubMed
27.
go back to reference Mohebati A, Shaha AR. Imaging techniques in parathyroid surgery for primary hyperparathyroidism. Am J Otolaryngol. 2012;33(4):457–68.CrossRef Mohebati A, Shaha AR. Imaging techniques in parathyroid surgery for primary hyperparathyroidism. Am J Otolaryngol. 2012;33(4):457–68.CrossRef
28.
go back to reference Yabuta T, et al. Ultrasonographic features of intrathyroidal parathyroid adenoma causing primary hyperparathyroidism. Endocr J. 2011;58(11):989–94.CrossRef Yabuta T, et al. Ultrasonographic features of intrathyroidal parathyroid adenoma causing primary hyperparathyroidism. Endocr J. 2011;58(11):989–94.CrossRef
29.
go back to reference Lalire P, et al. Incidental detection of oxyphilic papillary thyroid carcinoma by 18F-fluorocholine PET/CT. Clin Nucl Med. 2016;41(6):512–3.CrossRef Lalire P, et al. Incidental detection of oxyphilic papillary thyroid carcinoma by 18F-fluorocholine PET/CT. Clin Nucl Med. 2016;41(6):512–3.CrossRef
30.
go back to reference Vija RL, et al. Incidental finding of intrathyroid metastases of prostatic cancer on 18F-choline PET/CT. Clin Nucl Med. 2019;44(2):e101–3.CrossRef Vija RL, et al. Incidental finding of intrathyroid metastases of prostatic cancer on 18F-choline PET/CT. Clin Nucl Med. 2019;44(2):e101–3.CrossRef
31.
go back to reference Aziz AL, et al. Oncocytic adenoma of thyroid incidentally detected by 18F-fluorocholine PET/CT. J Nucl Med Technol. 2015;43(2):133–4.CrossRef Aziz AL, et al. Oncocytic adenoma of thyroid incidentally detected by 18F-fluorocholine PET/CT. J Nucl Med Technol. 2015;43(2):133–4.CrossRef
32.
go back to reference Ciappuccini R, et al. Thyroid incidentaloma on 18F-fluorocholine PET/CT and 68Ga-PSMA PET/CT revealing a medullary thyroid carcinoma. Clin Nucl Med. 2019;44(8):663–5.CrossRef Ciappuccini R, et al. Thyroid incidentaloma on 18F-fluorocholine PET/CT and 68Ga-PSMA PET/CT revealing a medullary thyroid carcinoma. Clin Nucl Med. 2019;44(8):663–5.CrossRef
33.
go back to reference Treglia G, et al. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2019;46(3):751–65.CrossRef Treglia G, et al. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2019;46(3):751–65.CrossRef
34.
go back to reference Calabria F, Chiaravalloti A, Schillaci O. (18)F-choline PET/CT pitfalls in image interpretation: an update on 300 examined patients with prostate cancer. Clin Nucl Med. 2014;39(2):122–30.CrossRef Calabria F, Chiaravalloti A, Schillaci O. (18)F-choline PET/CT pitfalls in image interpretation: an update on 300 examined patients with prostate cancer. Clin Nucl Med. 2014;39(2):122–30.CrossRef
Metadata
Title
The role of 18F-FCH PET/CT in patients with uremic hyperparathyroidism compared with 99mTc-sestaMIBI SPECT/CT and ultrasonography
Authors
Yu Xue
Wenbo Li
Zhu Xia
Chengming Lei
Yiyi Cao
Zhengjie Wang
Hua Pang
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
EJNMMI Research / Issue 1/2019
Electronic ISSN: 2191-219X
DOI
https://doi.org/10.1186/s13550-019-0583-9

Other articles of this Issue 1/2019

EJNMMI Research 1/2019 Go to the issue